General Information
Umeclidinium is a long-acting muscarinic antagonist (LAMA) used as maintenance treatment for symptoms of chronic obstructive pulmonary disease (COPD). It is available as a once-daily inhalation monotherapy or as a fixed-dose combination product with the long-acting beta2-agonist vilanterol.
About the API
Systematic name
diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide
Technology
High Potent
Molecular Formula
C29H34BrNO2
Molecular Weight
508.5 g/mol
Therapeutic category
Respiratory
Available formulations
Inhalation
Regulations
US DMF
US DMF